
Singapore central bank to place S$1.1 billion with asset managers to boost stock market
Published 21 Jul 2025, 10:01 AM IST
SINGORE, - Singapore's central bank will place S$1.1 billion with three asset managers as part of a S$5 billion programme to boost the stock market, it said on Monday, with more co-investments to be announced late this year. The move comes as part of an ongoing probe into the local stock market by the Monetary Authority of Singapore and a review group set up in August last year, with the aim of strengthening the way the market functions. The fund managers selected as part of Singapore's Equity Market Development Programme are Avanda Investment Management, JP Morgan Asset Management and Fullerton Fund Management, which is owned by Singapore's sovereign fund Temasek.
MAS said it considered "a range of factors" when choosing the managers, including the "alignment of their proposed fund strategies with EQDP objectives" and their commitment to contribute to the growth of Singapore's asset management capabilities.
It added that more than 100 global, regional and local asset managers have shown interest in receiving funds for co-investment under the development programme, and that it will review the submissions in batches to speed up the appointment of asset managers and the deployment of capital.
In February, MAS and the Financial Sector Development Fund announced that the S$5 billion programme would invest in strategies managed by Singapore-based asset managers that "have a strong focus on Singapore listed equities and broaden investor participation beyond large-cap stocks", the central bank said. Since Singapore announced that it would set up the review group to revive the stock market in August last year, the benchmark Straits Times Index had gained 23.9% as of July 18.
This article was generated from an automated news agency feed without modifications to text.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
11 minutes ago
- Economic Times
Jain Irrigation net profit declines 8.5% to Rs 11.19 crore in Jun quarter
Jain Irrigation Systems on Saturday reported an 8.5 per cent fall in consolidated net profit to Rs 11.19 crore for the latest quarter ended June 2025. ADVERTISEMENT Its net profit stood at Rs 12.23 crore in the year-ago period. The total income rose to Rs 1,547.68 crore in the April-June period of 2025-26 from Rs 1,479.24 crore in the corresponding period of the preceding year, according to a regulatory filing. Jain Irrigation Systems Vice Chairman and Managing Director Anil Jain said, "In Q1 of FY26, the company experienced good demand for Micro Irrigation Systems, Tissue Culture, Exports and Solar Agri Pumps. We saw good growth in revenue and margins in Hi-Tech Agri division".Due to the early monsoon in May, he said the company saw an impact on demand for pipe."Margins for pipe business were also under pressure due to lack of demand," Jain said. ADVERTISEMENT He said the company's focus towards retail and exports has shown better results in terms of revenue growth and margins."With well-spread monsoon and the government's commitment to investment in infrastructure, we expect revival of demand for piping business in H2FY26," Jain said. ADVERTISEMENT In 2024-25, the Maharashtra-based Jain Irrigation Systems had posted a net profit of Rs 25.69 crore on a total income of Rs 5,793.24 crore. The company is engaged in the manufacturing of micro irrigation systems, PVC P pipes, HDPE pipes, plastic sheets, agro-processed products, renewable energy solutions, tissue culture plants, financial services and other agricultural inputs. PTI (You can now subscribe to our ETMarkets WhatsApp channel)


Time of India
41 minutes ago
- Time of India
NephroPlus files DRHP with Sebi, to raise Rs 353 crore via fresh issue
Dialysis services provider Nephrocare Health Services Limited has filed the draft red herring prospectus ( DRHP ) with capital markets regulator Securities and Exchange Board of India ( Sebi ) to raise funds through an initial public offering (IPO). The company plans to raise Rs 353.4 crore via issue of fresh shares. According to the DRHP, the proposed IPO of the Hyderabad-based company is a combination of a fresh issue of equity shares and an offer for sale (OFS) of up to 1.27 crore equity shares by the selling shareholders. Explore courses from Top Institutes in Please select course: Select a Course Category Product Management Finance Others Data Science CXO Degree others Leadership Technology Artificial Intelligence MBA Digital Marketing Public Policy Operations Management Data Science Cybersecurity PGDM MCA Project Management Management Healthcare Design Thinking healthcare Data Analytics Skills you'll gain: Product Strategy & Competitive Advantage Tactics Product Development Processes & Market Orientations Product Analytics & Data-Driven Decision Making Agile Development, Design Thinking, & Product Leadership Duration: 40 Weeks IIM Kozhikode Professional Certificate in Product Management Starts on Jun 26, 2024 Get Details Skills you'll gain: Creating Effective Product Roadmap User Research & Translating it to Product Design Key Metrics via Product Analytics Hand-On Projects Using Cutting Edge Tools Duration: 12 Weeks Indian School of Business ISB Product Management Starts on May 14, 2024 Get Details Skills you'll gain: Product Strategy & Roadmapping User-Centric Product Design Agile Product Development Market Analysis & Product Launch Duration: 24 Weeks Indian School of Business Professional Certificate in Product Management Starts on Jun 26, 2024 Get Details by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Swelling and internal bleeding in the brain, help this baby Donate For Health Donate Now Undo As part of the OFS, the promoter selling shareholders include Investcorp Private Equity Fund II, Healthcare Parent Limited, Investcorp Growth Opportunity Fund and Edoras Investment Holdings Pte. Ltd. and Other Selling Shareholders include Investcorp India Private Equity Opportunity Limited, International Finance Corporation, 360 One Special Opportunities Fund - Series 9 and 360 One Special Opportunities Fund - Series 10. The company is in consultation with the Book Running Lead Managers (BRLMs) and may consider a pre-IPO Placement aggregating up to Rs 70.6 crore prior to filing of the Red Herring Prospectus (RHP) with the ROC. If the pre- IPO placement is undertaken, then the fresh issue will be reduced to the extent of such pre-IPO placement. About Nephrocare Health Services Live Events Known for its brand NephroPlus, the company claims to be Asia's largest dialysis services provider and fifth largest globally in terms of number of treatments performed in Fiscal 2025, citing F&S report. Incorporated in 2009, NephroPlus has 447 clinics across 269 cities in 21 states and 4 Union Territories. It serves more than 33,000 patients globally on an annual basis and has a revenue market share of over 50% in India's organised market (in terms of number of treatments), the draft filing said. It has also expanded its international footprint to include Philippines (34 clinics), Uzbekistan (4 clinics), Nepal (5 clinics) and has entered the Middle East market through the Kingdom of Saudi Arabia recently. Vikram Vuppala, BVP (Bessemer Venture Partners) Trust, Edoras Investment Holdings Pte. Ltd., Healthcare Parent Limited (HPL), Investcorp Private Equity Fund II (IPEF II) and Investcorp Growth Opportunity Fund (IGOF) are the promoters of the company. Nephrocare Health Services proceeds utilisation NephroPlus has proposed to utilise the net proceeds of the fresh issue towards capital expenditure to the tune of Rs 129.1 crore for opening new dialysis clinics in India. It will use Rs 136 crore for pre-payment or scheduled repayment of certain borrowings availed by the company and rest on general corporate purposes. In FY25, NephroPlus reported revenue from operations of Rs. 755.8 crore and profit after tax of Rs. 67 crore. Currently, kidney disease is the third fastest-growing cause of death globally and diabetes and hypertension have been recognized as the two leading drivers of chronic kidney disease (CKD). Rapid urbanization and lifestyle changes have further contributed to the increased incidence of CKD. ICICI Securities Limited, Ambit Private Limited, IIFL Capital Services Limited and Nomura Financial Advisory and Securities (India) Private Limited are the Book Running Lead Managers to the issue. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)


Time of India
43 minutes ago
- Time of India
Jain Irrigation net profit declines 8.5% to Rs 11.19 crore in Jun quarter
Jain Irrigation Systems on Saturday reported an 8.5 per cent fall in consolidated net profit to Rs 11.19 crore for the latest quarter ended June 2025. Its net profit stood at Rs 12.23 crore in the year-ago period. Explore courses from Top Institutes in Please select course: Select a Course Category Design Thinking Digital Marketing Project Management CXO Healthcare Degree Artificial Intelligence Leadership Finance PGDM Management Technology MCA others MBA healthcare Data Analytics Operations Management Cybersecurity Data Science Product Management Data Science Others Public Policy Skills you'll gain: Duration: 25 Weeks IIM Kozhikode CERT-IIMK PCP DTIM Async India Starts on undefined Get Details Skills you'll gain: Duration: 22 Weeks IIM Indore CERT-IIMI DTAI Async India Starts on undefined Get Details by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like War Thunder - Register now for free and play against over 75 Million real Players War Thunder Play Now Undo The total income rose to Rs 1,547.68 crore in the April-June period of 2025-26 from Rs 1,479.24 crore in the corresponding period of the preceding year, according to a regulatory filing. Jain Irrigation Systems Vice Chairman and Managing Director Anil Jain said, "In Q1 of FY26, the company experienced good demand for Micro Irrigation Systems, Tissue Culture, Exports and Solar Agri Pumps. We saw good growth in revenue and margins in Hi-Tech Agri division". Due to the early monsoon in May, he said the company saw an impact on demand for pipe. Live Events "Margins for pipe business were also under pressure due to lack of demand," Jain said. He said the company's focus towards retail and exports has shown better results in terms of revenue growth and margins. "With well-spread monsoon and the government's commitment to investment in infrastructure, we expect revival of demand for piping business in H2FY26," Jain said. In 2024-25, the Maharashtra-based Jain Irrigation Systems had posted a net profit of Rs 25.69 crore on a total income of Rs 5,793.24 crore. The company is engaged in the manufacturing of micro irrigation systems, PVC P pipes, HDPE pipes, plastic sheets, agro-processed products, renewable energy solutions, tissue culture plants, financial services and other agricultural inputs. PTI